(Q24654139)

English

A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire (English)

0 references

0 references

Newcastle disease

1 reference

based on heuristic

inferred from title

Newcastle disease virus

object named as

Newcastle disease virus

1 reference

based on heuristic

inferred from title

author name string

F M Batliwalla

1

0 references

B A Bateman

2

0 references

D Serrano

3

0 references

D Murray

4

0 references

S Macphail

5

0 references

V C Maino

6

0 references

J C Ansel

7

0 references

P K Gregersen

8

0 references

C A Armstrong

9

0 references

language of work or name

0 references

publication date

December 1998

0 references

Molecular Medicine

0 references

4

0 references

12

0 references

783-94

0 references

Tolerance, danger, and the extended family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

7 April 2017

Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Vaccine therapy for malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Oligoclonality in the human CD8+ T cell repertoire in normal subjects and monozygotic twins: implications for studies of infectious and autoimmune diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

A method for producing monoclonal antibodies to human T-cell-receptor beta-chain variable regions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

New developments in the virus therapy of cancer: a historical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Immunotherapy and gene therapy of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

The role of adjuvant therapy in melanoma management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Immunobiology and immunotherapy of melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Oligoclonality in the CD8+ T-cell population. Analysis using a multiplex PCR assay for CDR3 length.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Prognostic value of lymph node dissection in malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Viral oncolysates as human tumor vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

A method for production of antibodies to human T-cell receptor beta-chain variable regions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Viral oncolysate in the management of malignant melanoma. II. Clinical studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Viral oncolysate in the management of malignant melanoma.I. Preparation of the oncolysate and measurement of immunologic responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Malignant melanoma: prognostic indicators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 September 2017

In vitro expansion and analysis of T lymphocyte microcultures obtained from the vaccination sites of cancer patients undergoing active specific immunization with autologous Newcastle-disease-virus-modified tumour cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

30 May 2018

Treatment of stage II malignant melanoma patients with a Newcastle disease virus oncolysate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

30 May 2018

Malignant melanoma. Inflammatory mononuclear cell infiltrates in cerebral metastases during concurrent therapy with viral oncolysate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

30 May 2018

Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against V beta 17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

30 May 2018

In vitro and clinical characterisation of a newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

30 May 2018

A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

30 May 2018

Biostatistical basis of elective node dissection for malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

30 May 2018

NEWCASTLE DISEASE VIRUS AS AN ANTINEOPLASTIC AGENT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 November 2018

Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 November 2018

Effective anti-metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with Newcastle disease virus (NDV).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 November 2018

Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2230393

28 November 2018

Cutaneous melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutaneous malignant melanoma: prognostic guidelines for physicians and patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oligoclonal CD8+ T cells are preferentially expanded in the CD57+ subset

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deaths from melanoma--United States, 1973-1992

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of two T cell receptor alpha chains: dual receptor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer vaccines get a shot in the arm

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced lymphocyte subpopulations in patients with advanced or disseminated melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interim results of a phase II multicenter clinical trial evaluating the activity of a therapeutic allogeneic melanoma vaccine (theraccine) in the treatment of disseminated malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant melanoma: perspectives on incidence and its effects on awareness, diagnosis, and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant therapy for melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 10 production by human melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9990864

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24654139&oldid=1799787324"